Polio in Pakistan prompts India to implement border crossing vaccination campaign

NewsGuard 100/100 Score

Officials in Pakistan on Monday "announced targeted, three-day anti-polio campaigns in affected areas, which include Karachi and districts in the Federally Administered Tribal Areas," the Wall Street Journal's "India Real Time" blog reports. According to the Global Eradication Initiative, led by the WHO, 84 cases of type 1 polio have been reported in Pakistan so far this year, nearly twice as many cases as the country had recorded by this time last year, according to the blog.

The "news raised alarms in India, where authorities announced plans to vaccinate all children under the age of five crossing the Wagha border from Pakistan," the blog states. "Until recently India had one of the world's worst rates of polio infection," but "thanks to mass vaccination campaigns, the country has made significant progress against polio," the blog notes, adding that because of this success, "preventing the virus from re-entering the country has become a new focus of public policy" (Stancati, 9/20).


    http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

    Comments

    The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
    Post a new comment
    Post

    While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

    Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

    Please do not ask questions that use sensitive or confidential information.

    Read the full Terms & Conditions.

    You might also like...
    Bio Farma's Bio-TCV typhoid conjugate vaccine licensed in Indonesia following marketing approval